Even though two patients have been diagnosed with the same type of leukemia, they may not respond in the same way to the same treatment. Advanced testing, such as genetic and molecular testing, reveal that the underlying biology of cancer cells can be very different in those two patients. For example, specific abnormal proteins and genes may be identified in cancer cells in some patients but not in others.
Roswell Park researchers are working continually to develop new targeted therapies that will help turn the tide for our leukemia patients.
Search the Roswell Park Clinical Trials website to find open clinical research studies of targeted therapies for various types of leukemia.